<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>Table 1.
  <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml"> </span>
 </label>
 <caption>
  <title>Application of nanoparticles-based vaccine candidates against coronaviruses with some details regarding function and mechanism.</title>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <th align="left">NPs type (carrier)</th>
    <th align="left">Type of coronavirus (antigen)</th>
    <th align="left">Adjuvant</th>
    <th align="left">Target life system</th>
    <th align="left">Antiviral mechanism</th>
    <th align="left">Disadvantage</th>
    <th align="left">Ref.</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">Au NPs</td>
    <td align="left">Swine TGEV</td>
    <td align="left">Au NPs</td>
    <td align="left">Mice and rabbits</td>
    <td align="left">Increase of the peritoneal macrophages respiratory activity and plasma IFN-γ level</td>
    <td align="left"> </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B29">29</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Ferritin-based NPs</td>
    <td align="left">MERS-CoV (RBD antigen)</td>
    <td align="left">–</td>
    <td align="left">BALB/c mice</td>
    <td align="left">Induction of CD4
     <sup>+</sup> T cells and IFN-γ TNF-α responses
    </td>
    <td align="left">–</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B30">30</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Spike protein NPs</td>
    <td align="left">MERS-CoV</td>
    <td align="left">Aluminum</td>
    <td align="left">BALB/c mice</td>
    <td align="left">Induction of higher titers of neutralizing antibody and Th2 immune response without induction of Th1 immune response.</td>
    <td align="left">Imbalance of Th1/Th2 responses and short-term protection immunity.</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B31">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Hollow polymeric NPs</td>
    <td align="left">MERS-CoV (RBD antigen)</td>
    <td align="left">STING agonist (cdGMP)</td>
    <td align="left">C57BL/6 mice</td>
    <td align="left">Induction of higher levels of humoral responses and IgG2a antibodies without induction of lung eosinophilic immunopathology</td>
    <td align="left">–</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B32">32</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Au NPs</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Au NPs</td>
    <td align="left">BALB/c mice</td>
    <td align="left">Induction of IgG response</td>
    <td align="left">Fail to reduce eosinophilic infiltration</td>
    <td align="left">[
     <xref ref-type="bibr" rid="B33">33</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>cdGMP: Cyclic diguanylate monophosphate; CoV: Coronavirus; MERS: Middle East respiratory syndrome; NP: Nanoparticle; RBD: Receptor-binding domain; SARS: Severe acute respiratory syndrome; STING: Stimulator of interferon genes; TGEV: Transmissible gastroenteritis.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
